secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xencor Inc (XNCR)
CIK:        0001326732
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001628280-23-013066
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xencor appoints Nancy Valente as EVP, Chief Development Officer; board reduced to 7
--------------------------------------------------------------------------------

- Nancy Valente appointed EVP and Chief Development Officer effective May 1, 2023; she resigned from board.
- Valente previously SVP at Genentech/Roche; led development of GAZYVA, VENCLEXTA, POLIVY, HEMLIBRA.
- Compensation: $540K base salary, 50% bonus target, option grant for 235,778 shares ($3.9M), RSU grant of 39,269 shares ($1.3M).
- Allen Yang steps down as executive officer effective May 1 but stays in non-executive role.
- Board size reduced from 8 to 7 to eliminate vacant seat left by Valente.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326732/000162828023013066/0001628280-23-013066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326732/000162828023013066/xncr-20230424.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-013066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer